BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11130384)

  • 1. Pain expression and stimulus localisation in individuals with Down's syndrome.
    Hennequin M; Morin C; Feine JS
    Lancet; 2000 Dec; 356(9245):1882-7. PubMed ID: 11130384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
    Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative coherence studies in healthy volunteers and Down's syndrome patients from childhood to adult age.
    Schmid RG; Tirsch WS; Rappelsberger P; Weinmann HM; Pöppl SJ
    Electroencephalogr Clin Neurophysiol; 1992 Aug; 83(2):112-23. PubMed ID: 1378376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of short bones of the hand in children with Down's syndrome.
    Chumlea WC; Malina RM; Rarick GL; Seefeldt VD
    J Ment Defic Res; 1979 Jun; 23(2):137-50. PubMed ID: 226715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient pattern visual evoked potentials in children with Down's syndrome.
    Suttle CM; Turner AM
    Ophthalmic Physiol Opt; 2004 Mar; 24(2):91-9. PubMed ID: 15005673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.
    Meyerovitch J; Antebi F; Greenberg-Dotan S; Bar-Tal O; Hochberg Z
    Arch Dis Child; 2012 Jul; 97(7):595-8. PubMed ID: 22535238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of esophageal motor dysfunction in Down's syndrome.
    Zárate N; Mearin F; Hidalgo A; Malagelada JR
    Am J Gastroenterol; 2001 Jun; 96(6):1718-24. PubMed ID: 11419820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life span changes in the averaged evoked responses of Down's syndrome and nonretarded persons.
    Callner DA; Dustman RE; Madsen JA; Schenkenberg T; Beck EC
    Am J Ment Defic; 1978 Jan; 82(4):398-405. PubMed ID: 146432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down's syndrome.
    Phillips AC; Holland AJ
    PLoS One; 2011; 6(12):e28618. PubMed ID: 22205957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atlanto-occipital hypermobility in subjects with Down's syndrome.
    Matsuda Y; Sano N; Watanabe S; Oki S; Shibata T
    Spine (Phila Pa 1976); 1995 Nov; 20(21):2283-6. PubMed ID: 8553114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthesia and postoperative analgesia in surgical neonates with or without Down's syndrome: is it really different?
    Valkenburg AJ; van Dijk M; de Leeuw TG; Meeussen CJ; Knibbe CA; Tibboel D
    Br J Anaesth; 2012 Feb; 108(2):295-301. PubMed ID: 22201181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of neuromuscular tone and strength in Down's syndrome children.
    Morris AF; Vaughan SE; Vaccaro P
    J Ment Defic Res; 1982 Mar; 26(Pt 1):41-6. PubMed ID: 6210779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative somatosensory testing of pain threshold in individuals with mental retardation.
    Defrin R; Pick CG; Peretz C; Carmeli E
    Pain; 2004 Mar; 108(1-2):58-66. PubMed ID: 15109508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem auditory-evoked responses with and without sedation in autism and Down's syndrome.
    Sersen EA; Heaney G; Clausen J; Belser R; Rainbow S
    Biol Psychiatry; 1990 Apr; 27(8):834-40. PubMed ID: 2139583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry.
    Kao CH; Chen CC; Wang SJ; Yeh SH
    Nucl Med Commun; 1992 Oct; 13(10):773-5. PubMed ID: 1491844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study.
    Bergholdt R; Eising S; Nerup J; Pociot F
    Diabetologia; 2006 Jun; 49(6):1179-82. PubMed ID: 16575558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different visual development: norms for visual acuity in children with Down's syndrome.
    Zahidi AA; Vinuela-Navarro V; Woodhouse JM
    Clin Exp Optom; 2018 Jul; 101(4):535-540. PubMed ID: 29601092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory dysfunction in Down's Syndrome.
    Murphy C; Jinich S
    Neurobiol Aging; 1996; 17(4):631-7. PubMed ID: 8832638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.